Results 181 to 190 of about 3,370,988 (226)

Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy. [PDF]

JNCI Cancer Spectr
Saririan N, Bhamidipati D, Dey P, Persaud S, Chakraborty N, Tabatabai S, Gallagher G, Trivedi NU, Mitchell AP.   +8 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Authorship and Conflict of Interest Statement

Journal of Dental Sciences, 2018
doaj   +1 more source

Discrepancies in Conflict-of-Interest Disclosures Among Physicians Receiving Compensation for Monoclonal Antibody Drugs: Correspondence. [PDF]

J Gen Intern Med
Daungsupawong H, Wiwanitkit V.
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Errors in Conflict of Interest Disclosures.

JAMA Health Forum
europepmc   +2 more sources

Authorship and Conflict of Interest Statement

Journal of Dental Sciences, 2015
doaj   +1 more source

Correction: Managing institutional conflicts: Stakeholder accounts of communication between conflict of interest and technology transfer offices. [PDF]

PLoS One
PLOS ONE Staff.
europepmc   +1 more source

Omitted Conflict of Interest Disclosures.

JAMA Health Forum
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Conflicts of Interest, Conflicting Interests, and Interesting Conflicts, Part 3

The Journal of Clinical Ethics, 1996
J P, Orlowski, J K, Vinicky, S S, Edwards   +2 more
openaire   +2 more sources